ArticleCancer medicine2026

Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors.

Finn J Schulze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.